Is T38.905D a billable code?
Yes. T38.905D is a billable ICD-10-CM code and can be used on claims and superbills for dates of service from October 1, 2026 to September 30, 2027.
ICD-10-CM FY2027 diagnosis code
T38.905D: Adverse effect of unspecified hormone antagonists, subsequent encounter
Billable codeValid for dates of service October 1, 2026 to September 30, 2027
T38.905D is a billable ICD-10-CM diagnosis code for adverse effect of unspecified hormone antagonists, subsequent encounter. It is specific enough to use on an insurance claim, a superbill or a Good Faith Estimate.
Superbill GeneratorStart a superbill with T38.905D already added.Good Faith EstimateStart a cost estimate with T38.905D already added.CMS-1500 Claim FormFill a claim form with T38.905D in box 21.
Other codes in T38.905 Adverse effect of unspecified hormone antagonists
T38.905D questions
What does T38.905D mean?
T38.905D is the ICD-10-CM code for Adverse effect of unspecified hormone antagonists, subsequent encounter. It is in chapter 19, Injury, poisoning and certain other consequences of external causes (S00-T88).
Code titles come from the official ICD-10-CM files published by the CDC National Center for Health Statistics. Always check payer rules and the clinical record before billing.